About the Company
We do not have any company description for ENZO BIOCHEM INC at the moment.
Exchange
NYSE
Fundamental Data and Insider Transactions (Quarterly data) Full Screen
Loading the fundamentals chart...
Latest News on ENZO BIOCHEM INC
Enzo Biochem Shareholders Approve Merger with Bethpage
Enzo Biochem ( ($ENZB) ) has provided an update. On August 19, 2025, Enzo Biochem, Inc. held a special meeting of shareholders where they approved ...
Enzo Biochem, Inc. Reports Improved Financial Results for Q2 ... - Nasdaq
Enzo Biochem, Inc. announced its financial results for the fiscal second quarter ending January 31, 2025, highlighting improvements in revenue, gross margin, and operating profit.
Enzo Biochem, Inc. Reports Fiscal Q1 2024 Financial Results and ...
Enzo Biochem, Inc. announced its financial results for the first quarter of the fiscal year ending October 31, 2024, reporting revenues of $6.2 million, a 20% decline from the previous year ...
Enzo Biochem Inc. - The New York Times
Enzo Biochem Inc in Farmingdale, LI, begins building sales force of its own after terminating contract with Affymetrix, its principal distributor, and filing lawsuit accusing it of improperly ...
Enzo Biochem, Inc. Announces Date of Special Meeting of Shareholders
For Enzo Biochem: For Media: For Investors: Patricia Eckert, Interim CFO 631-755-5500 Lynn Granito Berry & Company Public Relations 212-253-8881 Chris Calabrese LifeSci Advisors, LLC 917-680-5608 and ...
Enzo Biochem, Inc. To be Acquired by Battery Ventures in All-Cash ...
Farmingdale, NY, June 24, 2025 (GLOBE NEWSWIRE) -- Enzo Biochem, Inc. (ENZB) (“Enzo” or the “Company”) today announced that on June 23, 2025, following the market close, it entered into an ...
Enzo Biochem Completes Sale of Clinical Laboratory to Labcorp
FARMINGDALE, NY, July 24, 2023 (GLOBE NEWSWIRE) -- Enzo Biochem, Inc. (NYSE:ENZ) today announced that it has closed a transaction to sell certain assets of Enzo’s Clinical laboratory division ...
Enzo Biochem, Inc. to Report First Quarter Fiscal 2023 Financial ...
Conference Call and Webcast Scheduled for December 13th, 8:30 AM ET New York, NY, Dec. 07, 2022 (GLOBE NEWSWIRE) -- Enzo Biochem, Inc. (NYSE:ENZ), a leading biosciences and diagnostics company ...
Enzo Biochem, Inc. (ENZ) Q4 2019 Results - Seeking Alpha
Enzo Biochem, Inc. (ENZ) Q4 2019 Results - Earnings Call Transcript Oct. 15, 2019 5:36 PM ET Enzo Biochem, Inc. (ENZB) Stock ENZB SA Transcripts 154.8K Follower s Play Earnings Call ...
Enzo Biochem Inc. Announces Issuance of United States Patent for ...
Enzo Biochem, Inc. (NYSE:ENZ) today announced that on May 7, 2019 it was issued U.S. Patent No. 10,278,960 entitled “Sphingosine Pathway Modulating Co ...
Enzo Biochem, Inc. To Be Acquired By Battery Ventures In All-Cash ...
Information about the directors and executive officers of Enzo is set forth in its Annual Report on Form 10-K for the fiscal year ended July 31, 2024, which was filed with the SEC on October 29 ...
Enzo Biochem, Inc. Announces Issuance of United States Patent for ...
Enzo Biochem, Inc. (NYSE:ENZ), an integrated diagnostics and therapeutics company, today announced the issuance of U.S. Patent No. 10,323,272 entitled ...
Similar Companies
Loading the latest forecasts...